Undiagnosed and ‘overdiagnosed’ COPD using postbronchodilator spirometry in primary healthcare settings: a systematic review and meta-analysis

Abstract

BackgroundDespite chronic obstructive pulmonary disease (COPD) being a major global cause of mortality and hospitalisation, it is often undiagnosed or inaccurately diagnosed in clinical settings.ObjectiveTo systematically synthesise all peer-reviewed papers from primary healthcare settings that have reported data on: (1) undiagnosed COPD, that is, patients with respiratory symptoms and postbronchodilator airflow obstruction consistent with COPD, without a formal clinician’s diagnosis of COPD either documented in health records or reported by patients and (2) ‘overdiagnosed COPD’, that is, clinician’s diagnosis without postbronchodilator airflow obstruction.MethodsStudies investigating these diagnostic metrics in patients from primary healthcare clinics (according to predefined inclusion/exclusion criteria) were sourced from Medline and Embase and assessed for bias (Johanna Briggs Institute tools for prevalence studies and case series). Meta-analyses of studies of adequate sample size used random effect modelling stratified by risk factor categories.ResultsOf 26 eligible articles, 21 cross-sectional studies investigated 3959 cases of spirometry-defined COPD (with or without symptoms), and 5 peer-reviewed COPD case series investigated 7381 patients. The prevalence of spirometry-confirmed COPD without a diagnosis documented in their health records was 14%–26% in studies of symptomatic smokers (N=3). 1 in 4 patients taking inhaled therapies (25% (95% CI 22% to 28%), N=2) and 1 in 6 smokers irrespective of symptoms (16% (95% CI 14% to 18%), N=6) fulfilled diagnostic spirometry criteria but did not report receiving a COPD-related diagnosis. In an adequately powered series of COPD cases documented in primary healthcare records (N=4), only between 50% and 75% of subjects had any airflow obstruction on postbronchodilator spirometry performed by study researchers, therefore, COPD was clinically ‘overdiagnosed’ in 25%–50% of subjects.DiscussionAlthough data were heterogeneous and of modest quality, undiagnosed COPD was common in primary healthcare, especially for symptomatic smokers and patients treated with inhaled therapies. In contrast, frequent COPD ‘overdiagnosis’ may represent treatment of asthma/reversible component or another medical diagnosis.PROSPERO registration numberCRD42022295832.

Association between chronic obstructive pulmonary disease and in-hospital mortality after percutaneous coronary intervention: a retrospective cohort study in Germany

“…The authors demonstrated that COPD was not documented in 14–26% smokers with spirometry-confirmable COPD. In addition, they demonstrated that 25–50% of patients diagnosed with COPD did not have an airflow obstruction 37 . Other studies also revealed that the absence of spirometry is a common cause for under- or over-diagnosis of COPD 38 , 39 .…”

Response to Various Biologics in Patients with Both Asthma and Chronic Obstructive Pulmonary Disease

“…However, these studies do not address and discuss the fact that these patients can have concomitant asthma. Of note, the only difference between the "COPD" population described in the BOREAS trial [4] and a typical population of patients with severe asthma was a smoking history of ≥10 PY (which does not exclude asthma [5]) and a doctor's diagnosis of COPD (which does not exclude the presence of asthma either [12,13]). Our study demonstrates that various types of biologics (and not only one class of biologic) approved for the treatment of asthma [6] can, depending on the respective asthma phenotype, be effective in patients with typical and defined clinical features of both asthma and COPD.…”

The Impact of Metabolic Syndrome Risk Factors on Lung Function Impairment: Cross-Sectional Study

“…Health professionals are on the frontline, and public health must provide strategies to diagnose and prevent lung disorders and protect and promote health [58], which has been advocated for years [59,60]. This idea gains relevance in a context where spirometry may be underused or, when used, misused [61,62].…”